Insider Trading activities of Biomarin Pharmaceutical Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Biomarin Pharmaceutical Inc since 2005. The reporting company's ticker symbol is BMRN. The reporting company's CIK number is 1048477.
The total value of stock buying since 2005 is $1,114,124.
The total value of stock sales since 2005 is $391,764,550.
The total value of stock option exercises since 2005 is $108,663,205.



Table 2. Detailed insider stock purchases, sales, and option exercises of Biomarin Pharmaceutical Inc insiders (BMRN) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-05-26 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 15,000 26.49 397,350
2016-05-23 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 3,769 87.08 328,185
2016-05-18 Baffi Robert (EVP, Technical Operations) Sale 5,000 87.05 435,250
2016-05-10 Davis George Eric (EVP, General Counsel) Sale 4,658 86.32 402,078
2016-05-09 Davis George Eric (EVP, General Counsel) Sale 10,000 84.55 845,530
2016-05-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 50,000 80.15 4,007,450
2016-05-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 70,000 24.18 1,692,810
2016-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 36,500 85.01 3,102,938
2016-05-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 36,500 12.99 474,135
2016-04-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 14.39 21,585
2016-04-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 14.39 21,585
2016-03-14 Davis George Eric (EVP, General Counsel) Sale 1,996 86.21 172,079
2016-03-04 Ajer Jeffrey Robert (SVP, Chief Commercial Officer) Sale 1,255 88.42 110,970
2016-03-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 4,623 86.12 398,118
2016-03-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 84.26 842,600
2016-02-22 Grey Michael G Sale 7,500 80.00 600,000
2016-02-22 Grey Michael G Option Ex 7,500 38.59 289,425
2015-12-16 Davis George Eric (SVP, General Counsel) Sale 1,362 100.00 136,200
2015-11-16 Lawlis V Bryan Sale 8,550 105.76 904,273
2015-11-16 Lawlis V Bryan Option Ex 7,500 17.33 129,974
2015-11-16 Grey Michael G Sale 7,500 104.27 782,055
2015-11-16 Grey Michael G Option Ex 7,500 38.59 289,425
2015-11-16 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 20,000 104.30 2,085,920
2015-11-16 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 20,000 39.06 781,200
2015-11-02 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 26 117.56 3,056
2015-10-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 108.24 108,241
2015-09-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 131.43 131,432
2015-09-08 Heron Elaine J Option Ex 15,000 21.51 322,650
2015-08-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 134.72 202,083
2015-07-20 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 3,000 150.00 450,000
2015-07-20 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 3,000 63.10 189,300
2015-07-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 139.07 208,599
2015-06-05 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 1,649 122.30 201,669
2015-06-05 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,864 122.32 228,000
2015-06-04 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 1,362 122.35 166,646
2015-06-01 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 377 123.76 46,656
2015-06-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 3,945 124.16 489,811
2015-05-29 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 1,578 126.15 199,064
2015-05-26 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 1,625 126.55 205,647
2015-05-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 126.11 189,157
2015-05-18 Davis George Eric (SVP, General Counsel) Sale 2,558 125.26 320,415
2015-05-18 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 36,137 127.39 4,687,045
2015-05-18 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,864 124.78 232,584
2015-05-13 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,434 121.36 174,037
2015-05-11 Fuchs Henry J (EVP, Chief Medical Officer) Sale 2,869 121.64 348,988
2015-05-06 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 34,019 119.17 4,053,942
2015-05-06 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 33,631 30.43 1,023,290
2015-05-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 26,723 114.98 3,072,503
2015-05-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 23,218 6.46 149,988
2015-05-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 414 114.59 47,441
2015-04-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 26,052 120.53 3,140,125
2015-04-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 22,546 6.46 145,647
2015-03-20 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 126.40 126,396
2015-03-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 124.87 124,866
2015-03-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 123.48 123,477
2015-03-16 Fuchs Henry J (EVP, Chief Medical Officer) Sale 41,315 123.57 5,105,170
2015-03-16 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 40,000 21.51 860,400
2015-03-13 Davis George Eric (SVP, General Counsel) Sale 15,000 120.87 1,813,005
2015-03-13 Davis George Eric (SVP, General Counsel) Option Ex 15,000 31.98 479,625
2015-03-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,021 114.89 232,200
2015-03-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 19,000 112.13 2,130,508
2015-03-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 12.99 194,850
2015-03-05 Baffi Robert (EVP, Technical Operations) Sale 14,051 116.37 1,635,086
2015-03-05 Baffi Robert (EVP, Technical Operations) Option Ex 14,051 16.12 226,572
2015-03-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 113.70 1,137,020
2015-03-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2015-03-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 916 107.71 98,660
2015-03-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 500 9.86 4,930
2015-03-03 Mueller Brian (VP, Corporate Controller) Sale 7,000 109.46 766,213
2015-03-03 Mueller Brian (VP, Corporate Controller) Option Ex 7,000 28.23 197,610
2015-03-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 107.42 537,095
2015-03-03 Lapalme Pierre Sale 20,000 106.57 2,131,400
2015-03-03 Lapalme Pierre Option Ex 20,000 14.24 284,800
2015-03-02 Davis George Eric (SVP, General Counsel) Sale 23,000 108.31 2,491,038
2015-03-02 Davis George Eric (SVP, General Counsel) Option Ex 23,000 26.49 609,270
2015-03-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 15,500 107.00 1,658,500
2015-03-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 15,500 39.06 605,430
2015-03-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 108.20 865,616
2015-03-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2015-01-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 94.14 188,286
2014-12-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 88.73 443,655
2014-12-24 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2014-12-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 95.00 190,000
2014-12-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-12-04 Lewis Alan Sale 7,500 89.90 674,227
2014-12-04 Lewis Alan Option Ex 7,500 21.51 161,325
2014-12-03 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 12,000 91.01 1,092,156
2014-12-03 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 12,000 38.59 463,080
2014-12-02 Mueller Brian (VP, Corporate Controller) Sale 5,000 91.82 459,099
2014-12-02 Mueller Brian (VP, Corporate Controller) Option Ex 5,000 28.23 141,150
2014-12-01 Mueller Brian (VP, Corporate Controller) Sale 6,950 90.25 627,237
2014-12-01 Mueller Brian (VP, Corporate Controller) Option Ex 6,950 17.95 124,752
2014-11-26 Mueller Brian (VP, Corporate Controller) Sale 3,400 88.97 302,508
2014-11-25 Davis George Eric (SVP, General Counsel) Sale 20,000 89.75 1,795,000
2014-11-25 Davis George Eric (SVP, General Counsel) Option Ex 20,000 26.49 529,800
2014-11-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 90.00 180,000
2014-11-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-11-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 81.51 81,513
2014-11-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 87.00 348,000
2014-11-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 12.99 51,960
2014-11-10 Fuchs Henry J (EVP, Chief Medical Officer) Sale 20,000 86.55 1,730,980
2014-11-10 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 20,000 21.51 430,200
2014-11-03 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 47 83.54 3,926
2014-11-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 85.33 256,002
2014-10-30 Davis George Eric (SVP, General Counsel) Sale 15,000 83.19 1,247,925
2014-10-30 Davis George Eric (SVP, General Counsel) Option Ex 15,000 26.49 397,350
2014-10-30 Baffi Robert (EVP, Technical Operations) Sale 29,963 81.70 2,447,947
2014-10-30 Baffi Robert (EVP, Technical Operations) Option Ex 29,963 38.59 1,156,272
2014-10-29 Baffi Robert (EVP, Technical Operations) Sale 45,462 81.10 3,686,968
2014-10-29 Baffi Robert (EVP, Technical Operations) Option Ex 45,462 24.49 1,113,227
2014-10-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 80.00 160,000
2014-10-24 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-10-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 75.00 150,000
2014-10-21 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-09-19 Davis George Eric (SVP, General Counsel) Sale 17,536 69.75 1,223,136
2014-09-19 Davis George Eric (SVP, General Counsel) Option Ex 17,536 21.51 377,199
2014-09-03 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 18 69.77 1,255
2014-09-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 16,000 69.83 1,117,312
2014-09-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 16,000 39.06 624,960
2014-08-20 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 70.00 350,000
2014-08-20 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2014-08-05 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 65.00 650,000
2014-08-05 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 21.51 215,100
2014-08-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 2,229 61.76 137,651
2014-07-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 2,229 64.00 142,656
2014-06-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 62.52 62,521
2014-06-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 59.88 59,876
2014-06-02 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 377 57.84 21,803
2014-05-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 56.88 56,876
2014-05-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,545 56.19 86,816
2014-05-16 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 1,004 56.91 57,135
2014-05-16 Lawlis V Bryan Sale 1,700 56.87 96,672
2014-05-16 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,864 56.86 105,994
2014-05-13 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 478 58.18 27,809
2014-05-13 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,434 58.23 83,497
2014-05-09 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 621 57.96 35,991
2014-05-09 Fuchs Henry J (EVP, Chief Medical Officer) Sale 3,479 57.91 201,475
2014-05-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 11 58.40 642
2014-05-01 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 666 59.55 39,660
2014-05-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 715 59.67 42,666
2014-03-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-03-06 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 17,370 78.63 1,365,837
2014-03-06 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 17,370 24.87 431,991
2014-03-05 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 12 82.93 995
2014-03-03 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 8,000 80.32 642,528
2014-03-03 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 8,000 39.06 312,480
2014-02-20 Davis George Eric (SVP, General Counsel) Sale 20,000 80.00 1,600,000
2014-02-20 Davis George Eric (SVP, General Counsel) Option Ex 20,000 21.51 430,200
2014-02-20 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 80.00 640,000
2014-02-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 12.99 51,960

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.